PAHC Financials Phibro Animal Health Corp

15 years of revenue, profit, cash flow and balance-sheet history through FY2026, from SEC filings — with a computed, factual read of the trend. Updated 20 d ago Overview →

Growth & profitability

Revenue has grown 12.7% per year over the past 5 years.
Net income has grown in line with revenue (12.9% vs 12.7% per year).
Operating margin has expanded, at 12.8% in the latest year.
Free cash flow has declined 12.3% per year over the past 5 years.

Financial health

Total debt has grown faster than revenue (29.9% vs 12.7% per year).
Operating income covered interest expense 4.2× in the latest year.

Shareholder returns

Dividends have been paid for 7 consecutive years, consuming 19.5% of earnings and 197.3% of free cash flow.
The dividend has grown 0.0% per year over the past 5 years.

Revenue & net income

RevenueNet income

Margins (gross / operating / net)

GrossOperatingNet

Return on equity & assets (ROE / ROA)

ROEROA

Free cash flow (CFO − capex)

Free cash flow

Cash vs total debt

CashTotal debt

Cash flow: operating / investing / financing

OperatingInvestingFinancing

Key annual figures

FY	Revenue	Net income	Gross M	Op M	ROE	ROA	FCF	Total debt	Cash
2026	$1.5B	$100M	33.8%	12.8%	25.9%	6.6%	$10M	—	$61M
2025	$1.3B	$48M	30.9%	8.5%	16.9%	3.5%	$42M	$632M	$68M
2024	$1.0B	$2M	30.8%	5.2%	0.9%	0.2%	$46M	$312M	$71M
2023	$978M	$33M	30.5%	7.3%	11.5%	3.4%	-$38M	$334M	$41M
2022	$942M	$49M	30.3%	8.4%	18.7%	5.3%	-$5M	$288M	$74M
2021	$833M	$54M	32.6%	9.0%	22.8%	6.5%	$19M	—	$50M
2020	$800M	$34M	32.1%	8.6%	17.8%	4.3%	$25M	—	$36M
2019	—	$55M	—	—	25.3%	7.5%	$17M	—	$58M
2018	—	$65M	—	—	35.1%	9.7%	$51M	—	$29M
2017	—	$65M	—	—	42.7%	10.4%	$78M	—	$56M
2016	—	$83M	—	—	91.4%	13.6%	$866000	—	$34M
2015	—	$60M	—	—	203.5%	12.2%	—	—	$29M
2014	—	-$3M	—	—	-20.6%	-0.7%	—	$286M	$12M
2013	—	$25M	—	—	-36.1%	5.2%	—	$298M	$27M
2012	—	$7M	—	—	-7.9%	—	—	—	$54M

Revenue & net income

RevenueNet income

Margins (gross / operating / net)

GrossOperatingNet

Return on equity & assets (ROE / ROA)

ROEROA

Free cash flow (CFO − capex, quarterly)

Free cash flow

Cash vs total debt

CashTotal debt

Cash flow: operating / investing / financing

OperatingInvestingFinancing

Key quarterly figures

Quarter	Revenue	Net income	Gross M	Op M	ROE	ROA	FCF	Total debt	Cash
Jun '26	$397M	$22M	33.9%	12.1%	5.6%	1.4%	$5M	—	$61M
Mar '26	$384M	$24M	32.8%	11.6%	6.6%	1.7%	$890000	$621M	$55M
Dec '25	$374M	$27M	35.5%	13.5%	8.3%	2.0%	$8M	$624M	$55M
Sep '25	$364M	$27M	32.9%	14.1%	8.5%	1.9%	-$5M	$628M	$73M
Jun '25	$379M	$17M	29.0%	8.9%	6.0%	1.3%	$8M	$632M	$68M
Mar '25	$348M	$21M	30.1%	9.6%	7.8%	1.6%	$35M	$635M	$60M
Dec '24	$309M	$3M	32.9%	8.3%	1.3%	0.2%	-$5M	$639M	$67M
Sep '24	$260M	$7M	32.1%	6.8%	2.7%	0.7%	$3M	$295M	$52M
Jun '24	$273M	$752000	31.9%	6.7%	0.3%	0.1%	$15M	$312M	$71M
Mar '24	$263M	$8M	30.2%	7.6%	3.1%	0.9%	$2M	$321M	$50M
Dec '23	$250M	$1M	31.5%	6.3%	0.5%	0.1%	$21M	$324M	$33M
Sep '23	$231M	-$8M	29.3%	-0.3%	-2.9%	-0.8%	$9M	$329M	$43M
Jun '23	$255M	$11M	30.1%	9.3%	4.1%	1.2%	$9M	$334M	$41M
Mar '23	$246M	$10M	30.7%	7.6%	3.7%	1.0%	-$2M	$288M	$37M
Dec '22	$245M	$7M	31.6%	6.5%	2.7%	0.7%	-$12M	$292M	$68M
Sep '22	$233M	$4M	29.5%	5.9%	1.5%	0.4%	-$34M	$296M	$76M
Jun '22	$255M	$7M	30.7%	9.0%	2.9%	0.8%	-$10M	$288M	$74M
Mar '22	$240M	$18M	29.9%	8.0%	6.6%	1.9%	-$4M	—	$71M
Dec '21	$233M	$17M	30.4%	9.6%	7.3%	2.1%	$12M	—	$63M
Sep '21	$215M	$7M	30.1%	6.8%	2.8%	0.8%	-$4M	—	$41M

Valuation over time

How the market has priced PAHC against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

The price-to-earnings ratio has risen from 12.6× (Mar '23) to 15.7× (Sep '26).
The price-to-sales ratio has risen from 0.7× (Mar '23) to 1.0× (Sep '26).
The dividend yield has fallen from 3.1% (Mar '23) to 1.2% (Sep '26).

Price / earnings (P/E)

P/E

Price / sales (P/S)

P/S

Dividend yield (%)

Dividend yield %

Frequently asked questions

Is PAHC growing its revenue and profit?

Over the past 5 years, Phibro Animal Health Corp's revenue has grown 12.7% per year, and net income grown 12.9% per year. These are computed facts, not advice.

How much debt does PAHC have?

As of FY2026, Phibro Animal Health Corp reported — of total debt against $61M of cash; operating income covered interest expense 4.2×.

What is PAHC's profit margin?

In FY2026, gross margin was 33.8%, operating margin 12.8%, and net margin 6.6%.

What is PAHC's P/E ratio?

As of Sep '26, Phibro Animal Health Corp traded at a price-to-earnings ratio of about 15.7× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S and dividend yield have moved with the share price. These are computed facts, not advice.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.